Financial Ratios American Well Corporation
Equities
AMWL
US03044L2043
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.990 USD | +0.76% | -4.46% | -73.39% |
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -11.78 | -15.15 | -8.27 | -12.68 | -17.38 | |
Return on Total Capital | -15.34 | -17.31 | -9.22 | -14.22 | -19.74 | |
Return On Equity % | -23.68 | -28.21 | -14.1 | -23.21 | -86.85 | |
Return on Common Equity | 32.35 | -48.95 | -14.32 | -23.48 | -88.37 | |
Margin Analysis | ||||||
Gross Profit Margin % | 46.27 | 36.07 | 41.27 | 42.13 | 36.58 | |
SG&A Margin | 67.44 | 90.25 | 66.6 | 80.24 | 80.56 | |
EBITDA Margin % | -57.4 | -88.59 | -67.51 | -88.07 | -87.24 | |
EBITA Margin % | -58.59 | -89.46 | -68.36 | -88.62 | -87.49 | |
EBIT Margin % | -62.62 | -92.73 | -73.87 | -97.51 | -96.99 | |
Income From Continuing Operations Margin % | -59.36 | -93.22 | -69.93 | -98.15 | -262.18 | |
Net Income Margin % | -58.57 | -91.51 | -69.76 | -97.56 | -260.63 | |
Net Avail. For Common Margin % | -58.57 | -91.51 | -69.76 | -97.56 | -260.63 | |
Normalized Net Income Margin | -36.02 | -56.39 | -46.74 | -59.48 | -55.01 | |
Levered Free Cash Flow Margin | -18.37 | -10.69 | -15.33 | -42.45 | -29.37 | |
Unlevered Free Cash Flow Margin | -18.37 | -10.69 | -15.33 | -42.45 | -29.37 | |
Asset Turnover | ||||||
Asset Turnover | 0.3 | 0.26 | 0.18 | 0.21 | 0.29 | |
Fixed Assets Turnover | 16.83 | 19.58 | 17.37 | 16.71 | 20.28 | |
Receivables Turnover (Average Receivables) | 4.69 | 6.29 | 5.23 | 5.05 | 4.6 | |
Inventory Turnover (Average Inventory) | 28.48 | 25.64 | 17.83 | 19.72 | 21.35 | |
Short Term Liquidity | ||||||
Current Ratio | 2.1 | 9.2 | 5.84 | 5.49 | 4.79 | |
Quick Ratio | 1.97 | 8.98 | 5.63 | 5.23 | 4.54 | |
Operating Cash Flow to Current Liabilities | -0.77 | -0.93 | -1 | -1.69 | -1.58 | |
Days Sales Outstanding (Average Receivables) | 77.86 | 58.22 | 69.79 | 72.26 | 79.27 | |
Days Outstanding Inventory (Average Inventory) | 12.82 | 14.28 | 20.48 | 18.51 | 17.09 | |
Average Days Payable Outstanding | 24.3 | 13.83 | 22.31 | 21.9 | 13.61 | |
Cash Conversion Cycle (Average Days) | 66.37 | 58.67 | 67.96 | 68.87 | 82.75 | |
Long Term Solvency | ||||||
Total Debt/Equity | 3.57 | 0.61 | 1.32 | 1.37 | 2.45 | |
Total Debt / Total Capital | 3.45 | 0.61 | 1.3 | 1.35 | 2.4 | |
LT Debt/Equity | 1.91 | 0.1 | 1.17 | 1.09 | 1.71 | |
Long-Term Debt / Total Capital | 1.84 | 0.1 | 1.15 | 1.07 | 1.67 | |
Total Liabilities / Total Assets | 25 | 9.48 | 12.79 | 10.98 | 18.57 | |
Total Debt / EBITDA | -0.17 | -0.04 | -0.1 | -0.06 | -0.05 | |
Net Debt / EBITDA | 2.08 | 4.91 | 4.42 | 2.19 | 1.62 | |
Total Debt / (EBITDA - Capex) | -0.17 | -0.04 | -0.1 | -0.06 | -0.05 | |
Net Debt / (EBITDA - Capex) | 2.05 | 4.83 | 4.41 | 2.19 | 1.62 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 30.63 | 64.77 | 3.07 | 9.65 | -6.55 | |
Gross Profit, 1 Yr. Growth % | 24.46 | 28.45 | 17.9 | 11.94 | -18.85 | |
EBITDA, 1 Yr. Growth % | 75.86 | 154.28 | -21.33 | 45.92 | -7.42 | |
EBITA, 1 Yr. Growth % | 73.77 | 151.58 | -21.12 | 44.97 | -7.73 | |
EBIT, 1 Yr. Growth % | 72.87 | 144 | -17.77 | 47.39 | -7.04 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 68.92 | 158.73 | -22.68 | 53.9 | 149.63 | |
Net Income, 1 Yr. Growth % | 65.53 | 157.41 | -21.43 | 53.36 | 149.66 | |
Normalized Net Income, 1 Yr. Growth % | 65.93 | 157.92 | -14.44 | 42.08 | -13.57 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 63.29 | 6.92 | -69.37 | 42.08 | 140.87 | |
Accounts Receivable, 1 Yr. Growth % | 6.34 | 38.39 | 13.42 | 13.62 | -7.24 | |
Inventory, 1 Yr. Growth % | 23.57 | 194.07 | -17.51 | 16.03 | -23.86 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 374.75 | -28.5 | 78.62 | -22.17 | -24.08 | |
Total Assets, 1 Yr. Growth % | 2.16 | 175.39 | 5.03 | -15.79 | -51.57 | |
Tangible Book Value, 1 Yr. Growth % | 36.19 | -272.66 | -33.92 | -23.36 | -30.32 | |
Common Equity, 1 Yr. Growth % | 32.47 | -498.58 | 1.24 | -14.15 | -56.37 | |
Cash From Operations, 1 Yr. Growth % | 10.66 | 37.33 | 25.85 | 35.88 | -22.87 | |
Capital Expenditures, 1 Yr. Growth % | -29.98 | 147.98 | -83.15 | -47.76 | -34.25 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | -4.15 | 49.06 | 221.01 | -35.33 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | -4.15 | 49.06 | 221.01 | -35.33 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 46.71 | 30.32 | 6.31 | 1.23 | |
Gross Profit, 2 Yr. CAGR % | - | 26.44 | 23.06 | 14.88 | -4.69 | |
EBITDA, 2 Yr. CAGR % | - | 111.46 | 41.32 | 6.08 | 21.3 | |
EBITA, 2 Yr. CAGR % | - | 109.08 | 40.76 | 5.89 | 20.63 | |
EBIT, 2 Yr. CAGR % | - | 105.38 | 41.54 | 9.16 | 21.69 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - |